Hikma Pharmaceutical reported 349M in EBITDA for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
AstraZeneca AZN:LN 292568.43M 24571.33M
Bayer BAYN:GR € 4762M 490M
Fresenius FRE:GR € 1381M 115M
Galapagos GLPG:NA € -43.87M 28.24M
GlaxoSmithKline GSK:LN 244700M 1400M
Hikma Pharmaceutical HIK:LN 349M 19M
Lonza Group LONN:SW 956M 167M
Merck MRK:GR € 1791M 161M
Orion ORNBV:FH € 83.1M 0.1M
Recordati REC:IM € 155M 8.05M